|

FT836 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 836

Pipeline

Phase 1: 1

Top Sponsors

  • Fate Therapeutics1

Indications

  • Endometrial Carcinoma1
  • Head and Neck Squamous Cell Carcinoma1
  • Ovarian Cancer1
  • Colorectal Cancer1
  • Lung Cancer1

Minneapolis, Minnesota1 trial

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

University of Minnesota Masonic Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.